Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/39426
Title: Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells.
Authors: Ooi J.D.;Tan Y.H.;Huynh M.;Willett Z.J.;Ramarathinam S.H.;Eggenhuizen P.J.;Loh K.L.;Watson K.A.;Gan P.Y.;Alikhan M.A.;Dudek N.L.;Handel A.;Hudson B.G.;Fugger L.;Power D.A.;Holt S.G.;Coates P.T.;Gregersen J.W.;Purcell A.W.;La Gruta N.L.;Reid H.H.;Rossjohn J. ;Kitching A.R. ;Holdsworth S.R. ;Petersen J.
Monash Health Department(s): Nephrology
Institution: (Ooi, Huynh, Willett, Eggenhuizen, Gan, Alikhan, Holdsworth, Kitching) Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Clayton, VIC 3168, Australia (Petersen, Tan, Ramarathinam, Loh, Dudek, Purcell, La Gruta, Reid, Rossjohn) Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia (Petersen, Reid, Rossjohn) Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, VIC 3800, Australia (Watson, La Gruta) Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3010, Australia (Handel) Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, Georgia 30602, United States (Hudson) Department of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN 37232, United States (Fugger) Oxford Centre for Neuroinflammation, Nuffield Department of Clinical Neurosciences, MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, United Kingdom (Power) Department of Nephrology, Austin Health, Heidelberg, VIC 3084, Australia (Power, Holt) Department of Medicine, University of Melbourne, Melbourne, VIC 3010, Australia (Holt) Department of Nephrology, The Royal Melbourne Hospital, Parkville, VIC 3050, Australia (Coates) Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, SA 5000, Australia (Gregersen) Department of Medicine, Viborg Regional Hospital, Viborg 8800, Denmark (Holdsworth, Kitching) Department of Nephrology, Monash Health, Clayton, VIC 3168, Australia (Rossjohn) Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, United Kingdom (Kitching) NHMRC Centre for Personalised Immunology, Monash University, Clayton, VIC 3168, Australia (Kitching) Department of Pediatric Nephrology, Monash Health, VIC 3168, Australia (Watson) Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia
Issue Date: 26-May-2017
Copyright year: 2017
Publisher: Nature Publishing Group (Houndmills, Basingstoke, Hampshire RG21 6XS, United Kingdom)
Place of publication: United Kingdom
Publication information: Nature. 545 (7653) (pp 243-247), 2017. Date of Publication: 11 May 2017.
Journal: Nature
Abstract: Susceptibility and protection against human autoimmune diseases, including type I diabetes, multiple sclerosis, and Goodpasture disease, is associated with particular human leukocyte antigen (HLA) alleles. However, the mechanisms underpinning such HLA-mediated effects on self-tolerance remain unclear. Here we investigate the molecular mechanism of Goodpasture disease, an HLA-linked autoimmune renal disorder characterized by an immunodominant CD4+ T-cell selfepitope derived from the a3 chain of type IV collagen (a3135-145)1-4. While HLA-DR15 confers a markedly increased disease risk, the protective HLA-DR1 allele is dominantly protective in trans with HLA-DR15 (ref. 2). We show that autoreactive a3135-145-specific T cells expand in patients with Goodpasture disease and, in a3135-145- immunized HLA-DR15 transgenic mice, a3135-145-specific T cells infiltrate the kidney and mice develop Goodpasture disease. HLA-DR15 and HLA-DR1 exhibit distinct peptide repertoires and binding preferences and present the a3135-145 epitope in different binding registers. HLA-DR15-a3135-145 tetramer+ T cells in HLA-DR15 transgenic mice exhibit a conventional T-cell phenotype (Tconv) that secretes pro-inflammatory cytokines. In contrast, HLADR1- a3135-145 tetramer+ T cells in HLA-DR1 and HLA-DR15/DR1 transgenic mice are predominantly CD4+Foxp3+ regulatory T cells (Treg cells) expressing tolerogenic cytokines. HLA-DR1-induced Treg cells confer resistance to disease in HLA-DR15/DR1 transgenic mice. HLA-DR15+ and HLA-DR1+ healthy human donors display altered a3135-145-specific T-cell antigen receptor usage, HLADR15- a3135-145 tetramer+ Foxp3- Tconv and HLA-DR1-a3135-145 tetramer+ Foxp3+CD25hiCD127lo Treg dominant phenotypes. Moreover, patients with Goodpasture disease display a clonally expanded a3135-145-specific CD4+ T-cell repertoire. Accordingly, we provide a mechanistic basis for the dominantly protective effect of HLA in autoimmune disease, whereby HLA polymorphism shapes the relative abundance of self-epitope specific Treg cells that leads to protection or causation of autoimmunity.Copyright © 2017 Macmillan Publishers Limited, part of Springer Nature.
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1038/nature22329
PubMed URL: 28467828 [http://www.ncbi.nlm.nih.gov/pubmed/?term=28467828]
ISSN: 0028-0836
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/39426
Type: Article
Appears in Collections:Articles

Show full item record

Page view(s)

30
checked on Oct 5, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.